KALA BIO, Inc. (KALA) stock
KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.19+0.00 (+1.42%)
Close on Oct 19, 2026Market cap $14.28KP/E –Yield –
Kala Bio gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2019 | Mar 31, 2019 | $1.15M | – |
See a number that looks wrong?